Related Experiment Video
Updated: Dec 8, 2025
Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
21 Code of Federal Regulations Part 11-Compliant Digital Signature Solution for Cancer Clinical Trials: A
Therica M Miller1, Jenny Lester2, Lorna Kwan3
1Hartford Healthcare Cancer Institute, Hartford, CT.
Purpose:
Inefficiencies in the clinical trial infrastructure result in protracted trial completion timelines, physician-investigator turnover, and a shrinking skilled labor force and present obstacles to research participation. Taken together, these barriers hinder scientific progress. Technological solutions to improve clinical trial efficiency have emerged, yet adoption remains slow because of concerns with cost, regulatory compliance, and implementation.
Methods:
A prospective pilot study that compared regulatory-compliant digital and traditional wet ink paper signatures was conducted over a 6.5-month period in a hospital-based health system. Staff time and effort, error rate, costs, and time to completion were measured. Wilcoxon rank sum tests were used to compare staff time and time to completion. A value analysis was conducted. A survey was administered to measure user satisfaction.
Results:
There where 96 participants (47 digital, 49 paper), 132 studies included (31 digital, 101 paper), and 265 documents processed (156 digital, 109 paper). A moderate reduction in staff time required to prepare documents for signature was observed (P < .0001). Error rates were reported in 5.1% of digital and 2.8% of paper documents, but this difference was not significant. Discrepancies requiring revisions included incomplete mandatory fields, inaccurate information submitted, and technical issues. A value analysis demonstrated a 19% labor savings with the use of digital signatures. Survey response rate was 57.4% (n = 27). Most participants (85.2%) preferred digital signatures. The time to complete documents was faster with digital signatures compared with paper (P = .0241).
Conclusion:
The use of digital signatures resulted in a decrease in document completion time and regulatory burden as represented by staff hours. Additional cost and time savings and information liquidity could be realized by integrating digital signatures and electronic document management systems.
Insights
Digital signatures significantly reduce clinical trial document completion times and staff hours, offering a more efficient alternative to traditional paper methods. This technology streamlines processes and improves overall research participation by addressing key infrastructure inefficiencies.
Area of Science:
- Clinical research operations
- Health informatics
- Regulatory compliance
Background:
- Clinical trial inefficiencies, including long timelines and workforce challenges, impede scientific progress.
- Slow adoption of technological solutions is attributed to cost, regulatory, and implementation concerns.
Purpose of the Study:
- To compare the efficiency and user satisfaction of regulatory-compliant digital signatures versus traditional wet ink signatures in a clinical setting.
- To evaluate the impact of digital signatures on staff time, error rates, costs, and document completion time.
Main Methods:
- A prospective pilot study conducted over 6.5 months in a hospital-based health system.
- Comparison of digital and paper signatures across 132 studies and 265 documents.
- Measurement of staff time, error rates, costs, and completion times; statistical analysis using Wilcoxon rank sum tests; value analysis; and user satisfaction survey.
Main Results:
- Digital signatures moderately reduced staff time for document preparation (P < .0001).
- No significant difference in error rates between digital (5.1%) and paper (2.8%) documents.
- Value analysis showed a 19% labor saving with digital signatures; document completion time was significantly faster with digital signatures (P = .0241).
- 85.2% of users preferred digital signatures.
Conclusions:
- Digital signatures decrease document completion time and regulatory burden (staff hours).
- Integration with electronic document management systems can yield further cost, time, and information liquidity benefits.
- Digital signature technology offers a viable solution to improve clinical trial efficiency and address infrastructure barriers.
Related Concept Videos
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment